Wendy Leisenring

Publication List Details

Period

2004 - 2009

Number

19

Co-Authors

Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study (2009)

Armstrong, Gregory T., Liu, Qi, Yasui, Yutaka, Huang, Sujuan, Ness, Kirsten K., Leisenring, Wendy, ...

Background Adult survivors of childhood central nervous system (CNS) malignancies are at high risk for long-term morbidity and late mortality. However, patterns of late mortality, the long-term risks...

Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study (2008)

Mertens, Ann C., Liu, Qi, Neglia, Joseph P., Wasilewski, Karen, Leisenring, Wendy, Armstrong, Gregory T., ...

Background The proportion of pediatric and adolescent cancer patients surviving 5 years has increased during the past four decades. This growing population of survivors remains at risk for disease-...

TI - Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation. (2008)

Sorror, Mohamed L, Leisenring, Wendy, Mielcarek, Marco, Baron, Frédéric, Diaconescu, Razvan, Hogan, William J, ...

BACKGROUND: Late graft rejection after conditioning with 1 Gy of total body irradiation (TBI) was consistently seen in historical dogs given two postgrafting immunosuppressive drugs. METHODS: Here,...

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker (2006)

Margaret Sullivan Pepe, Holly Janes, Gary Longton, Wendy Leisenring

A marker strongly associated with outcome (or disease) is often assumed to be effective for classifying persons according to their current or future outcome. However, for this assumption to be true,...

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation (2005)

Burroughs, Lauri, Leisenring, Wendy, Diaconescu, Razvan, Martin, Paul J, Sandmaier, Brenda M, ...

We retrospectively analysed outcomes among 395 patients with haematologic malignancies who underwent non-myeloablative haematopoietic cell transplantation (HCT) from human leucocyte antigen...

Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic or Prognostic Marker (2005)

Pepe, Margaret S., Janes, Holly, Longton, Gary M., Leisenring, Wendy, Newcomb, Polly

A marker that is strongly associated with outcome (or disease) is often assumed to be effective for classifying individuals according to their current or future outcome. However, for this to be true,...

Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic or Prognostic Marker (2005)

Pepe, Margaret S., Janes, Holly, Longton, Gary M., Leisenring, Wendy, Newcomb, Polly

A marker that is strongly associated with outcome (or disease) is often assumed to be effective for classifying individuals according to their current or future outcome. However, for this to be true,...

Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic or Prognostic Marker (2005)

Pepe, Margaret S., Janes, Holly, Longton, Gary M., Leisenring, Wendy, Newcomb, Polly

A marker that is strongly associated with outcome (or disease) is often assumed to be effective for classifying individuals according to their current or future outcome. However, for this to be true,...

Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic or Prognostic Marker (2005)

Pepe, Margaret S., Janes, Holly, Longton, Gary M., Leisenring, Wendy, Newcomb, Polly

A marker that is strongly associated with outcome (or disease) is often assumed to be effective for classifying individuals according to their current or future outcome. However, for this to be true,...

Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker (2004)

Pepe, Margaret Sullivan, Janes, Holly, Longton, Gary, Leisenring, Wendy, Newcomb, Polly

A marker strongly associated with outcome (or disease) is often assumed to be effective for classifying persons according to their current or future outcome. However, for this assumption to be true,...

Convenient Selective Differential Broth for Isolation of Vancomycin-Resistant Enterococcus from Fecal Material

Novicki, Thomas J., Schapiro, Jeffrey M., Ulness, Bruce K., Sebeste, Ann, Busse-Johnston, Laurel, Swanson, Kristine M., ...

Studies have shown that vancomycin broth enrichment is superior to direct plating for the detection of vancomycin-resistant enterococcus (VRE), but vancomycin selective broth is not generally...

Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid

Musher, Benjamin, Fredricks, David, Leisenring, Wendy, Balajee, S. Arunmozhi, Smith, Caitlin, Marr, Kieren A.

Invasive pulmonary aspergillosis (IPA) is frequent and often fatal in hematopoietic stem cell transplant patients. Diagnosis requires microbiological or histopathologic demonstration of the organism...

Reproducibility of Low Galactomannan Enzyme Immunoassay Index Values Tested in Multiple Laboratories

Upton, Arlo, Gugel, Anja, Leisenring, Wendy, Limaye, Ajit, Alexander, Barbara, Hayden, Randall, ...

The Platelia galactomannan enzyme immunoassay is a commercially available nonculture method for diagnosing invasive aspergillosis. Recently, steps have been taken to improve sensitivity;...

Convenient Selective Differential Broth for Isolation of Vancomycin-Resistant Enterococcus from Fecal Material

Novicki, Thomas J., Schapiro, Jeffrey M., Ulness, Bruce K., Sebeste, Ann, Busse-Johnston, Laurel, Swanson, Kristine M., ...

Studies have shown that vancomycin broth enrichment is superior to direct plating for the detection of vancomycin-resistant enterococcus (VRE), but vancomycin selective broth is not generally...

Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid

Musher, Benjamin, Fredricks, David, Leisenring, Wendy, Balajee, S. Arunmozhi, Smith, Caitlin, Marr, Kieren A.

Invasive pulmonary aspergillosis (IPA) is frequent and often fatal in hematopoietic stem cell transplant patients. Diagnosis requires microbiological or histopathologic demonstration of the organism...

Reproducibility of Low Galactomannan Enzyme Immunoassay Index Values Tested in Multiple Laboratories

Upton, Arlo, Gugel, Anja, Leisenring, Wendy, Limaye, Ajit, Alexander, Barbara, Hayden, Randall, ...

The Platelia galactomannan enzyme immunoassay is a commercially available nonculture method for diagnosing invasive aspergillosis. Recently, steps have been taken to improve sensitivity;...

Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic or Prognostic Marker

Margaret Pepe, Holly Janes, Gary Longton, Wendy Leisenring, Polly Newcomb

A marker that is strongly associated with outcome (or disease) is often assumed to be effective for classifying individuals according to their current or future outcome. However, for this to be true,...

Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party

Friedman, Debra L., Rovo, Alicia, Leisenring, Wendy, Locasciulli, Anna, Flowers, Mary E. D., Tichelli, Andre, ...

As risk for secondary breast cancer is elevated among cancer survivors treated with conventional therapy, we sought to determine the risk among 3337 female 5-year survivors who underwent an...